微创食管癌切除术在临床上的应用

[Clinical application of minimally invasive esophagectomy for esophageal carcinoma].

作者信息

Liu Shuo-yan, Wang Feng, Zheng Qing-feng, Chen Xiao-feng

机构信息

Department of Thoracic Surgery, Fujian Medical University Teaching Hospital, Fuzhou, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Sep;15(9):947-9.

PMID:22990930

Abstract

OBJECTIVE

To investigate the feasibility and safety of minimally invasive esophagectomy (MIE) for esophageal carcinoma.

METHODS

Clinical data of 298 esophageal carcinoma cases who were treated by MIE in the Fujian Provincial Cancer Hospital from June 2008 to April 2012 were retrospectively reviewed.

RESULTS

All the patients underwent MIE successfully except one conversion to open surgery. The mean operative time was (242.3±58.7) min. The postoperative length of hospital stay was (17.4±9.8) d. The number of harvested lymph nodes of total, the mediastinum, the abdomen and the cervix was 27.5±12.2, 10.7±5.7, 13.3±7.8, and 7.7±8.1, respectively. Postoperative complication rate was 29.9%, including pneumonia (n=41), recurrent laryngeal nerve injury (n=25), anastomotic leak (n=9), wound infection (n=7), and others (n=7). After follow up of 2 to 47 months, 3 patients were found to develop anastomotic stricture. There were no recurrence, metastasis, or death.

CONCLUSION

Minimally invasive esophagectomy is a safe, feasible, effective and minimally invasive surgical technique.

摘要

目的

探讨微创食管癌切除术（MIE）治疗食管癌的可行性及安全性。

方法

回顾性分析2008年6月至2012年4月在福建省肿瘤医院接受MIE治疗的298例食管癌患者的临床资料。

结果

除1例中转开腹手术外，所有患者均成功接受MIE。平均手术时间为（242.3±58.7）分钟。术后住院时间为（17.4±9.8）天。总的、纵隔、腹部及颈部清扫淋巴结数目分别为27.5±12.2、10.7±5.7、13.3±7.8和7.7±8.1。术后并发症发生率为29.9%，包括肺炎（n=41）、喉返神经损伤（n=25）、吻合口漏（n=9）、伤口感染（n=7）及其他（n=7）。随访2至47个月，发现3例患者出现吻合口狭窄。无复发、转移或死亡病例。